Literature DB >> 8751115

Myopia of adult onset. Can analyses be based on patient memory?

H C Fledelius1.   

Abstract

One hundred and fifty-one adult subjects (age 26-64 years) with simple myopia ('simple' = absence of significant astigmatism and anisometropia) were asked about their myopia onset, here defined as the age when first having spectacles to correct vision trouble for distance. A precise memory appeared in 148. Usually, they could substantiate their information by detailed accounts regarding how and when. Evidently, the first pair of glasses is a strong emotional experience. Accordingly, information appears to be reliable when properly asking the patient. The sample confirmed established knowledge: the earlier the onset, the higher the final myopia. Adult onset myopia is usually low, but occasionally intermediate or high myopia cases are encountered. Adult onset myopia appears more frequently than evident from textbooks and literature on refractive distribution. A frequency estimate based on Danish material thus suggests that at least 25-30% of all adult age myopia is also of adult onset.

Entities:  

Mesh:

Year:  1995        PMID: 8751115     DOI: 10.1111/j.1600-0420.1995.tb00295.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  3 in total

1.  Distribution of refractive errors in Spain.

Authors:  R Montes-Micó; T Ferrer-Blasco
Journal:  Doc Ophthalmol       Date:  2000-07       Impact factor: 2.379

Review 2.  The Role of GJD2(Cx36) in Refractive Error Development.

Authors:  Emilie van der Sande; Annechien E G Haarman; Wim H Quint; Kirke C D Tadema; Magda A Meester-Smoor; Maarten Kamermans; Chris I De Zeeuw; Caroline C W Klaver; Beerend H J Winkelman; Adriana I Iglesias
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-03-02       Impact factor: 4.799

3.  Genome-wide analysis points to roles for extracellular matrix remodeling, the visual cycle, and neuronal development in myopia.

Authors:  Amy K Kiefer; Joyce Y Tung; Chuong B Do; David A Hinds; Joanna L Mountain; Uta Francke; Nicholas Eriksson
Journal:  PLoS Genet       Date:  2013-02-28       Impact factor: 5.917

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.